Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis

Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial

(2021) Geltrude Mingrone et al.   LANCET

Non-alcoholic fatty liver disease

(2021) Elizabeth E Powell et al.   LANCET

Patient-reported Outcomes After Metabolic Surgery Versus Medical Therapy for Diabetes

(2021) Ali Aminian et al.   ANNALS OF SURGERY

Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus

(2021) Daniel Ferguson et al.   Nature Reviews Endocrinology

American Society for Metabolic and Bariatric Surgery 2018 estimate of metabolic and bariatric procedures performed in the United States

(2020) Wayne J. English et al.   Surgery for Obesity and Related Diseases

Overlap Weighting

(2020) Laine E. Thomas et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Nonalcoholic Steatohepatitis

(2020) Adam C. Sheka et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis

(2020) Guillaume Lassailly et al.   GASTROENTEROLOGY

A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis

(2020) Philip N. Newsome et al.   NEW ENGLAND JOURNAL OF MEDICINE

Nonalcoholic Fatty Liver Disease and the Heart

(2019) Eric P. Stahl et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity

(2019) Ali Aminian et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Obeticholic acid: towards first approval for NASH

(2019) Mohammed Eslam et al.   LANCET

Lifestyle Intervention and Medical Management With vs Without Roux-en-Y Gastric Bypass and Control of Hemoglobin A1c, LDL Cholesterol, and Systolic Blood Pressure at 5 Years in the Diabetes Surgery Study

(2018) Sayeed Ikramuddin et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Unknown

(2018)   PHARMACEUTICAL STATISTICS

Association Between Bariatric Surgery and Macrovascular Disease Outcomes in Patients With Type 2 Diabetes and Severe Obesity

(2018) David P. Fisher et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The Benefit of Sleeve Gastrectomy in Obese Adolescents on Nonalcoholic Steatohepatitis and Hepatic Fibrosis

(2017) Melania Manco et al.   JOURNAL OF PEDIATRICS

Balancing Covariates via Propensity Score Weighting

(2017) Fan Li et al.   JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION

Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes

(2017) Philip R. Schauer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis

(2017) Anna M. Diehl et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of Bariatric Surgery in Obese Patients With Hypertension

(2017) Carlos Aurelio Schiavon et al.   CIRCULATION

Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study

(2016) Matthew James Armstrong et al.   LANCET

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

(2015) Brent A Neuschwander-Tetri et al.   LANCET

Association of Bariatric Surgery With Long-term Remission of Type 2 Diabetes and With Microvascular and Macrovascular Complications

(2014) Lars Sjöström et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

(2010) Arun J. Sanyal et al.   NEW ENGLAND JOURNAL OF MEDICINE